Cost-Effectiveness of selecting an Enantiopure formulation over a racemic mixture

Simple item page
dc.contributor.advisorKapp, Erika
dc.contributor.authorLekuni, Olivia
dc.date.accessioned2018-10-03T07:42:42Z
dc.date.accessioned2024-10-29T14:20:14Z
dc.date.available2018-12-31T22:10:06Z
dc.date.available2024-10-29T14:20:14Z
dc.date.issued2017
dc.descriptionMagister Scientiae - MSc (Pharmacy Administration and Policy Regulation)
dc.description.abstractThe aim of this study is to provide more information in terms of the cost-effectiveness of selecting an enantiopure formulation over a racemic mixture in the context of promoting rational use of medicines. This was done by comparing costs and efficacy of escitalopram versus citalopram and esomeprazole versus omeprazole since they are the most commonly used medicines with both racemate and enantiopure products registered.
dc.identifier.urihttps://hdl.handle.net/10566/16390
dc.language.isoen
dc.publisherUniversity of the Western Cape
dc.rights.holderUniversity of the Western Cape
dc.subjectEnantiopure Chirality Cost-effectiveness Efficacy Racemic, Regulatory, Omeprazole, someprazole, Citalopram, Escitalopram
dc.titleCost-Effectiveness of selecting an Enantiopure formulation over a racemic mixture

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
2874-3517-1-RV.pdf
Size:
3.18 MB
Format:
Adobe Portable Document Format
Download

Collections

Magister Scientiae - MSc (Pharmacy Administration and Policy Regulation)